Yahoo Finance • 5 hours ago
AstraZeneca has agreed to lower prescription drug costs for Medicaid under a deal with the Trump administration View Comments... Full story
Yahoo Finance • 5 hours ago
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal View Comments... Full story
Yahoo Finance • 13 hours ago
[Genetic research and Biotech science Concept. Human Biology and pharmaceutical technology] jittawit.21 What's the most attractive biotech stock right now for investors? Seeking Alpha analysts ONeil Trader [https://seekingalpha.com/autho... Full story
Yahoo Finance • 2 days ago
Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for... Full story
Yahoo Finance • 2 days ago
Pascal Soriot (left), AstraZeneca’s chief executive, has said the US has shouldered a “disproportionate portion” of drug costs - Alex Brandon/AP AstraZeneca has pledged to slash drug prices in the US as it pressures the NHS to pay more fo... Full story
Yahoo Finance • 2 days ago
The agreement, which entails offering “most-favored nation” drug pricing, follows Pfizer’s deal to reduce prices for its drugs sold in the Medicaid program and through a new direct-purchasing service to be branded TrumpRx. Continue Readin... Full story
Yahoo Finance • 2 days ago
AstraZeneca on Friday became the second big drugmaker after Pfizer to cut a pricing deal with the White House, announcing an agreement alongside President Donald Trump at a late afternoon press conference. AstraZeneca stock was up 1.6% in... Full story
Yahoo Finance • 2 days ago
STORY: :: Trump says AstraZeneca will sell some medicines to the U.S. at discounted prices:: October 10, 2025:: Washington, D.C."Today, AstraZeneca is committing to offer all of their prescription medications to Medicaid at most favored na... Full story
Yahoo Finance • 3 days ago
AstraZeneca is the latest major drugmaker to strike a deal with the Trump administration on lowering U.S. drug prices, according to a person familiar with the matter. The agreement and its details, which have yet to be disclosed, follow la... Full story
Yahoo Finance • 3 days ago
Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story
Yahoo Finance • 3 days ago
[AstraZeneca company office building] Robert Way * President Trump at 5p ET Friday will say that AstraZeneca has made a deal with the Trump administration to cut the prices of its drugs, following in the footsteps of Pfizer's (PFE) agre... Full story
Yahoo Finance • 3 days ago
Health care stocks were lower Friday afternoon, with the NYSE Health Care Index and the Health Care PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story
Yahoo Finance • 4 days ago
New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies Facility marks cornersto... Full story
Yahoo Finance • 4 days ago
NORWALK, Conn., Oct. 9, 2025 /PRNewswire/ -- Lifespan Vision Ventures congratulates its portfolio company, Algen Biotechnologies, on the announcement of its multi-target research collaboration with AstraZeneca to advance AI-powered drug di... Full story
Yahoo Finance • 4 days ago
LONDON, UK and BUDAPEST, HUNGARY, Oct. 9, 2025 /PRNewswire/ -- Turbine, a leading company specializing in virtualizing biological experiments with AI, today announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) to test the abili... Full story
Yahoo Finance • 4 days ago
Company Logo The bispecific antibodies market presents key opportunities in oncology, autoimmune, and infectious diseases, driven by rapid technological advancements and strategic collaborations. Regional manufacturing and diverse supplie... Full story
Yahoo Finance • 4 days ago
The United Kingdom's stock market has recently faced challenges, as evidenced by the FTSE 100 index closing lower due to weak trade data from China and declining commodity prices affecting key sectors. In this environment, investors may fi... Full story
Yahoo Finance • 5 days ago
Mikael Dolsten, M.D., Ph.D., chairman of TRIO Pharmaceuticals SAN CARLOS, Calif., October 08, 2025--(BUSINESS WIRE)--TRIO Pharmaceuticals, a biotechnology company advancing novel multi-functional antibody treatments for cancers with high... Full story
Yahoo Finance • 5 days ago
If you own AstraZeneca stock or are thinking about jumping in, this is one of those moments that begs your attention. With the share price rallying 14.3% in just the last week and up 20.2% since January, it is pretty obvious something is s... Full story
Yahoo Finance • 6 days ago
AUSTIN, Texas and TOKYO, Oct. 7, 2025 /PRNewswire/ -- The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene therapy, antisense oligonucleotides (ASOs), monoclonal antib... Full story